TABLE 2.
Isotype(s) | Sampleb | Ab levels to antigena
|
|||||
---|---|---|---|---|---|---|---|
Peptide RESA | Peptide MSP1-Nt | Peptide MSP2-Nt | Peptide MSP2-Ct1 | Peptide MSP2-Ct2 | Extract | ||
IgG1 | P1 | NS | NS | NS | NS | NS | 0.28 (<10−4) |
P2 | NS | NS | NS | 0.20 (0.002) | NS | 0.16 (0.015) | |
IgG2 | P1 | 0.51 (<10−4) | 0.43 (<10−4) | 0.42 (<10−4) | 0.39 (<10−4) | 0.40 (<10−4) | 0.59 (<10−4) |
P2 | 0.56 (<10−4) | 0.57 (<10−4) | 0.58 (<10−4) | 0.61 (<10−4) | 0.63 (<10−4) | 0.65 (<10−4) | |
IgG3 | P1 | 0.24 (0.001) | 0.29 (<10−4) | 0.30 (<10−4) | 0.31 (<10−4) | 0.17 (0.016) | 0.54 (<10−4) |
P2 | 0.22 (0.001) | 0.22 (0.001) | 0.23 (<10−3) | 0.20 (0.002) | 0.24 (<10−3) | 0.40 (<10−4) | |
IgG4 | P1 | NS | NS | NS | NS | NS | 0.20 (0.004) |
P2 | NS | NS | −0.14 (0.030) | NS | NS | 0.19 (0.004) | |
IgG | P1 | 0.15 (0.029) | 0.16 (0.025) | NS | NS | NS | 0.47 (<10−4) |
P2 | 0.38 (<10−4) | 0.24 (<10−4) | 0.35 (<10−4) | 0.27 (<10−4) | 0.29 (<10−4) | 0.41 (<10−4) | |
IgG1/IgG4 | P1 | NS | NS | NS | NS | NS | NS |
P2 | 0.14 (0.029) | NS | 0.21 (0.001) | 0.20 (0.002) | 0.15 (0.020) | NS | |
IgG2/IgG4 | P1 | 0.16 (0.024) | NS | NS | NS | 0.18 (0.011) | 0.50 (<10−4) |
P2 | 0.44 (<10−4) | 0.38 (<10−4) | 0.46 (<10−4) | 0.48 (<10−4) | 0.50 (<10−4) | 0.46 (<10−4) | |
IgG3/IgG4 | P1 | NS | NS | NS | NS | 0.15 (0.032) | 0.33 (<10−4) |
P2 | 0.25 (<10−4) | 0.21 (0.001) | 0.29 (<10−4) | 0.25 (<10−4) | 0.29 (<10−4) | 0.26 (<10−4) |
Results are expressed as Spearman's correlation coefficient. The levels of significance are given in parentheses. NS, not significant.
Blood samples were taken before the season of transmission (P1) and at the end of the season of transmission (P2).